My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

741.85 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,701
Open 741.85
Bid (Size) 736.40 (1)
Ask (Size) 738.40 (1)
Prev. Close 741.85
Today's Range 741.85 - 741.85
52wk Range 623.78 - 939.30
Shares Outstanding 956,580,893
Dividend Yield 0.81%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering.
Investors once speculated that Pfizer might consider acquiring Viking. 
Via The Motley Fool
3 Small-Cap Stocks We Keep Off Our Radar
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory

Performance

YTD
-4.7%
-4.7%
1 Month
+6.7%
+6.7%
3 Month
-6.4%
-6.4%
6 Month
-10.3%
-10.3%
1 Year
-19.8%
-19.8%

More News

Read More
Healthcare Sector Grapples with 5% Slump in 2025: A Deep Dive into Market Underperformance
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Eli Lilly Announces Plan To Construct New $6.5B Facility In Texas
Via Stocktwits
Chinese Biotech Takes Aim At Eli Lilly, Novo Nordisk With New GLP-1 Weight-Loss Drugs As Patent Clocks Tick
Via Stocktwits
Topics Intellectual Property
Does Eli Lilly's New $5 Billion Drug Manufacturing Facility Make It a Long-Term Buy?
Via The Motley Fool
Topics Artificial Intelligence Economy
United Kingdom The Worst European Country For Drug Prices: Eli Lilly CEO
Via Benzinga
Direxion's Ultra-Leveraged CURE ETF Offers An Opportunity To Play The Potential Valuation Reset
Via Benzinga
Topics ETFs
STRATA Skin Sciences Soars as Landmark Study Reveals Superior Vitiligo Treatment Efficacy
Via MarketMinute
Topics Intellectual Property
The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning
Via Benzinga
What's Pfizer Getting in Its $7.3 Billion Metsera Buyout?
Via The Motley Fool
Nvidia’s $100B Bet in OpenAI Pushes Wall Street to Fresh Records
Via Chartmill
Topics Economy
Unpacking the Latest Options Trading Trends in Eli Lilly
Via Benzinga
Top 5 Stocks to Watch in Q4 2025: Navigating a Shifting Economic Landscape
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Big Pharma's Epicenter Shift: Eli Lilly and the Reshaping of the Weight-Loss Drug Market
Via MarketMinute
Topics Economy Intellectual Property
Roche Targets Top Spot In Weight Loss Drug Market
Via Benzinga
Healthcare Sector Outlook: Navigating Regulatory Headwinds and Breakthrough Innovations
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Growth Titans: Eli Lilly's Weight-Loss Surge vs. Johnson & Johnson's Diversified Might
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Eli Lilly's Ascent: A New Era in Obesity Treatment Driven by Zepbound and Orforglipron
Via MarketMinute
Topics Economy
NVIDIA's AI Engine Roars On: Data Center Dominance Fuels Stellar Q2, But Market Seeks More
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Is Eli Lilly Stock a Buy After Gaining 10% in 1 Month?
Via The Motley Fool
Pfizer Reportedly Nears Metsera Acquisition Deal: PFE Stock Climbs In Monday Pre-Market
Via Benzinga
1 ETF to Buy Before the End of 2025
Via The Motley Fool
Topics ETFs
Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
2 Magnificent S&P 500 Dividend Stocks Down 7% and 19% to Buy and Hold Forever
Via The Motley Fool
Topics Economy Stocks

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 741.85
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 09/24/25 07:00 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 709.64B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 710B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.